×

2-ethyl and 2-ethylidene-19-nor-vitamin D compounds

  • US 7,300,925 B2
  • Filed: 11/22/2006
  • Issued: 11/27/2007
  • Est. Priority Date: 05/31/2000
  • Status: Expired due to Term
First Claim
Patent Images

1. A method of treating psoriasis comprising administering to a patient with psoriasis an effective amount of a compound selected from the group consisting of:

  • 19-nor-2α

    -ethyl-1α

    ,25-dihydroxyvitamin D3,19-nor-2β

    -ethyl-1α

    ,25-dihydroxyvitamin D3,19-nor-20(S)-2α

    -ethyl-1α

    ,25-dihydroxyvitamin D3,19-nor-20(S)-2β

    -ethyl-1α

    ,25-dihydroxyvitamin D3,19-nor-2(E)-ethylidene-1α

    ,25-dihydroxyvitamin D3,19-nor-2(Z)-ethylidene-1α

    ,25-dihydroxyvitamin D3,19-nor-2(E)-ethylidene-20(S)-1α

    ,25-dihydroxyvitamin D3, and19-nor-2(Z)-ethylidene-20(S)-1α

    ,25-dihydroxyvitamin D3.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×